
Vaccine manufacturer Moderna said Tuesday the US Food and Drug Administration was refusing to review an application for its first mRNA-based flu shot. The move comes as the current iteration of the FDA has called for a reconsideration of approval procedures for certain vaccines, including for influenza — proposed federal policy changes under President Donald […]
The post Moderna says US refusing to review mRNA-based flu shot appeared first on Insider Paper.
© Gist Notes. All Rights Reserved.